E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding

Jason H. Rogers, Kristin S. Owens, Jeffrey Kurkewich, Nathan Klopfenstein, Sangeeta R. Iyer, M. Celeste Simon, Richard Dahl

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Antagonistic interactions between transcription factors contribute to cell fate decisions made by multipotent hematopoietic progenitor cells. Concentration of the transcription factor PU.1 affects myeloid/lymphoid development with high levels of PU.1 directing myeloid cell fate acquisition at the expense of B cell differentiation. High levels of PU.1 may be required for myelopoiesis in order to overcome inhibition of its activity by transcription factors that promote B cell development. The B cell transcription factors, E2A and EBF, are necessary for commitment of multipotential progenitors and lymphoid primed multipotential progenitors to lymphocytes. In this report we hypothesized that factors required for early B cell commitment would bind to PU.1 and antagonize its ability to induce myeloid differentiation. We investigated whether E2A and/or EBF associate with PU.1. We observed that the E2A component, E47, but not EBF, directly binds to PU.1. Additionally E47 represses PU.1-dependent transactivation of the MCSFR promoter through antagonizing PU.1's ability to bind to DNA. Exogenous E47 expression in hematopoietic cells inhibits myeloid differentiation. Our data suggest that E2A antagonism of PU.1 activity contributes to its ability to commit multipotential hematopoietic progenitors to the lymphoid lineages.

Original languageEnglish (US)
Article number3983686
JournalBioMed Research International
Volume2016
DOIs
StatePublished - 2016

Fingerprint

Aptitude
B-Lymphocytes
Cells
Transcription Factors
DNA
Myeloid Cells
Myelopoiesis
Lymphocytes
Hematopoietic Stem Cells
Transcriptional Activation
Cell Differentiation
Inhibition (Psychology)

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Rogers, J. H., Owens, K. S., Kurkewich, J., Klopfenstein, N., Iyer, S. R., Simon, M. C., & Dahl, R. (2016). E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding. BioMed Research International, 2016, [3983686]. https://doi.org/10.1155/2016/3983686

E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding. / Rogers, Jason H.; Owens, Kristin S.; Kurkewich, Jeffrey; Klopfenstein, Nathan; Iyer, Sangeeta R.; Simon, M. Celeste; Dahl, Richard.

In: BioMed Research International, Vol. 2016, 3983686, 2016.

Research output: Contribution to journalArticle

Rogers, JH, Owens, KS, Kurkewich, J, Klopfenstein, N, Iyer, SR, Simon, MC & Dahl, R 2016, 'E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding', BioMed Research International, vol. 2016, 3983686. https://doi.org/10.1155/2016/3983686
Rogers JH, Owens KS, Kurkewich J, Klopfenstein N, Iyer SR, Simon MC et al. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding. BioMed Research International. 2016;2016. 3983686. https://doi.org/10.1155/2016/3983686
Rogers, Jason H. ; Owens, Kristin S. ; Kurkewich, Jeffrey ; Klopfenstein, Nathan ; Iyer, Sangeeta R. ; Simon, M. Celeste ; Dahl, Richard. / E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding. In: BioMed Research International. 2016 ; Vol. 2016.
@article{f9d27eae42cc4b22aa8cb2bc98adf616,
title = "E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding",
abstract = "Antagonistic interactions between transcription factors contribute to cell fate decisions made by multipotent hematopoietic progenitor cells. Concentration of the transcription factor PU.1 affects myeloid/lymphoid development with high levels of PU.1 directing myeloid cell fate acquisition at the expense of B cell differentiation. High levels of PU.1 may be required for myelopoiesis in order to overcome inhibition of its activity by transcription factors that promote B cell development. The B cell transcription factors, E2A and EBF, are necessary for commitment of multipotential progenitors and lymphoid primed multipotential progenitors to lymphocytes. In this report we hypothesized that factors required for early B cell commitment would bind to PU.1 and antagonize its ability to induce myeloid differentiation. We investigated whether E2A and/or EBF associate with PU.1. We observed that the E2A component, E47, but not EBF, directly binds to PU.1. Additionally E47 represses PU.1-dependent transactivation of the MCSFR promoter through antagonizing PU.1's ability to bind to DNA. Exogenous E47 expression in hematopoietic cells inhibits myeloid differentiation. Our data suggest that E2A antagonism of PU.1 activity contributes to its ability to commit multipotential hematopoietic progenitors to the lymphoid lineages.",
author = "Rogers, {Jason H.} and Owens, {Kristin S.} and Jeffrey Kurkewich and Nathan Klopfenstein and Iyer, {Sangeeta R.} and Simon, {M. Celeste} and Richard Dahl",
year = "2016",
doi = "10.1155/2016/3983686",
language = "English (US)",
volume = "2016",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding

AU - Rogers, Jason H.

AU - Owens, Kristin S.

AU - Kurkewich, Jeffrey

AU - Klopfenstein, Nathan

AU - Iyer, Sangeeta R.

AU - Simon, M. Celeste

AU - Dahl, Richard

PY - 2016

Y1 - 2016

N2 - Antagonistic interactions between transcription factors contribute to cell fate decisions made by multipotent hematopoietic progenitor cells. Concentration of the transcription factor PU.1 affects myeloid/lymphoid development with high levels of PU.1 directing myeloid cell fate acquisition at the expense of B cell differentiation. High levels of PU.1 may be required for myelopoiesis in order to overcome inhibition of its activity by transcription factors that promote B cell development. The B cell transcription factors, E2A and EBF, are necessary for commitment of multipotential progenitors and lymphoid primed multipotential progenitors to lymphocytes. In this report we hypothesized that factors required for early B cell commitment would bind to PU.1 and antagonize its ability to induce myeloid differentiation. We investigated whether E2A and/or EBF associate with PU.1. We observed that the E2A component, E47, but not EBF, directly binds to PU.1. Additionally E47 represses PU.1-dependent transactivation of the MCSFR promoter through antagonizing PU.1's ability to bind to DNA. Exogenous E47 expression in hematopoietic cells inhibits myeloid differentiation. Our data suggest that E2A antagonism of PU.1 activity contributes to its ability to commit multipotential hematopoietic progenitors to the lymphoid lineages.

AB - Antagonistic interactions between transcription factors contribute to cell fate decisions made by multipotent hematopoietic progenitor cells. Concentration of the transcription factor PU.1 affects myeloid/lymphoid development with high levels of PU.1 directing myeloid cell fate acquisition at the expense of B cell differentiation. High levels of PU.1 may be required for myelopoiesis in order to overcome inhibition of its activity by transcription factors that promote B cell development. The B cell transcription factors, E2A and EBF, are necessary for commitment of multipotential progenitors and lymphoid primed multipotential progenitors to lymphocytes. In this report we hypothesized that factors required for early B cell commitment would bind to PU.1 and antagonize its ability to induce myeloid differentiation. We investigated whether E2A and/or EBF associate with PU.1. We observed that the E2A component, E47, but not EBF, directly binds to PU.1. Additionally E47 represses PU.1-dependent transactivation of the MCSFR promoter through antagonizing PU.1's ability to bind to DNA. Exogenous E47 expression in hematopoietic cells inhibits myeloid differentiation. Our data suggest that E2A antagonism of PU.1 activity contributes to its ability to commit multipotential hematopoietic progenitors to the lymphoid lineages.

UR - http://www.scopus.com/inward/record.url?scp=84958074578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958074578&partnerID=8YFLogxK

U2 - 10.1155/2016/3983686

DO - 10.1155/2016/3983686

M3 - Article

VL - 2016

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 3983686

ER -